BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10, 2025, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, “BBLG,”.

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 27 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution, UroGen's first approved product, and the c.

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present four posters at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress, taking place June 13-16, 2025 in Glasgow, United Kingdom. Dr. William Yang, M.D., FRCPC, FAAAAI, Managing Director and Chair, Ottawa Allergy Research Corporation, will present combined i.

BOCA RATON, FL, June 06, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic partnership with Drift Protocol, the leading decentralized derivatives exchange on Solana with $1B in deposits.

Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD. EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, the incidence of sexual side effects experienced with EXXUA was comparable to placebo.

FORT PIERCE, FL / ACCESS Newswire / June 6, 2025 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, proudly announces the acquisition of Bahama Boat Works, uniting two renowned legacies in the marine industry. The iconic Bahama brand, long celebrated for its unmatched craftsmanship, timeless aesthetic, and dedication to producing some of the finest offshore fishing vessels, will continue to uphold these standards under Twin Vee.

BOISE, Idaho--(BUSINESS WIRE)-- #BuiltOnRelationships--KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Pivot Pointe, a new community in desirable Meridian, Idaho. The new homes are designed for the way people live today, with popular features like modern kitchens overlooking large great rooms, bedroom suites with walk-in closets, and ample storage space. Pivot Pointe's two-story floor plans feature up to five bedrooms and three baths. Homeowners w.

PATRIOTISM MEETS HORSEPOWER: ANDY ROSS TO IGNITE BRISTOL DRAGWAY WITH ELECTRIFYING PERFORMANCE! NASHVILLE, TN, June 06, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), is excited to report that American Rebel CEO Andy Ross will perform at the Super Grip NHRA Thunder Valley Nationals Saturday, June 7, on the Midway Stage from 1:45 to 2:45 pm.

BETHESDA, Md.--(BUSINESS WIRE)--RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today announced it will report financial results for the second quarter ended June 30, 2025, after the markets close on August 7, 2025. The Company will also host a conference call on August 8, 2025, at 10:00 a.m. (Eastern Time). The Company recommends that you dial in approximately 10 minutes before the call. The conference call can be accessed by dialing (877) 407-3982 or (201) 493-6780 for international participant.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences:

Franklin Income Equity Focus ETF is a derivative income ETF with option strategies embedded in equity-linked notes. INCE has value characteristics and is well-balanced across sectors, with significant exposure in technology. INCE has reached its objective to provide lower volatility than the S&P 500.

DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 2, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 401,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with …

DocuSign beat earnings and revenue estimates for Q1'26. The company remained highly FCF profitable and expanded its core subscription business. The market overreacted to lower billings, causing a 17% share price drop after-hours, which I see as a buying opportunity given the company's fundamentals. DocuSign generated solid free cash flow margins of 30% and raised its FY 2026 revenue outlook.

BEIJING , June 6, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced that it will release its financial results for the first quarter 2025 ended March 31, 2025, before the U.S. market opens on June 12, 2025. Uxin's management team will host a conference call on Thursday, June 12, 2025, at 8:00 A.M.

- Robert Infarinato named VP, Strategic Development - Lisa Carson named as new VP, Finance and Administration Marlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to treat cancer. Phio announced today a strategic initiative to heighten awareness of potential applications of the broader INTASYL siRNA portfolio, which includes approximately 30 compounds.

MONTREAL , June 6, 2025 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE Inc. ("CAE") today announced that it has received regulatory approval to renew its normal course issuer bid ("NCIB") to purchase, for cancellation, up to 16,019,294 of its common shares commencing June 10, 2025 and ending June 9, 2026. The maximum number of common shares that may be repurchased under the program represents approximately five percent (5%) of the issued and outstanding common shares of CAE.

Nvidia Corp. (NASDAQ: NVDA) stock has bounced from a recent year-to-date low.

We're at the end of earnings season. That means it's time for analysts to weigh in on the outlook for specific stocks.

Dan Ives, Global Head of Tech at Wedbush, defends Tesla's long-term value despite Musk-Trump tensions. Sarah Kunst of Cleo Capital warns regulatory risks could hurt Tesla, SpaceX, and investor faith.

RESTON, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd.